Amgen saw the highest growth of 0.87% in patent filings in May and 0.9% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.8% and grants by 0.87%. GlobalData’s DataBook provides a comprehensive analysis of Amgen‘s patent filings and grants. Buy the databook here.
Amgen has been focused on protecting inventions in United States(US) with 91 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 20% filings and 23% grants. The United States(US), Australia(AU), European Patent Office(EPO), and Japan(JP) patent Office are among the top ten patent offices where Amgen is filings its patents. Among the top granted patent authorities, Amgen has 23% of its grants in United States(US), 15% in Israel(IL) and 9% in Australia(AU).
Roche could be the strongest competitor for Amgen
In terms of grant share, Amgen stands in fifth position among its competitors. Amgen and Roche secured the top positions according to recent patent publication data.
Patents related to rare diseases and industrial automation lead Amgen's portfolio
Amgen has the highest number of patents in rare diseases followed by, industrial automation and remote patient monitoring. For rare diseases, nearly 28% of patents were filed and 35% of patents were granted in Q2 2024.
Drug delivery devices related patents lead Amgen portfolio followed by carcinomas, and pancreatic cancer
Amgen has highest number of patents in drug delivery devices followed by carcinomas, pancreatic cancer, colorectal tumor, and petrochemicals. For drug delivery devices, nearly 6% of patents were filed and 5% of patents were granted in Q2 2024.
For comprehensive analysis of Amgen's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.